Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults.
Nicholas A. Carlisle, Haley Maria Dourron, Sarah Maccarthy, Ali John Zarrabi, Peter S. Hendricks
Psychedelic Med (New Rochelle) December 13, 2023 DOI: 10.1089/psymed.2022.0018 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractChronic shame, often stemming from internalized stigma, disproportionately affects sexual and gender minority (SGM) adults and undermines mental health. This theoretical and philosophical paper argues that psychedelic-assisted therapy holds unique potential to reduce such shame by disrupting rigid self-narratives and fostering self-compassion. The authors suggest that the pharmacological and contextual features of psychedelic experiences—particularly enhanced emotional openness and mystical-type experiences—may directly target shame-related neural and psychological processes. They propose that psychedelic therapy could offer SGM individuals a reparative pathway toward healing and psychological wellness, distinct from conventional treatments. The paper calls for further empirical investigation into psychedelics as a tailored intervention for chronic shame in this population.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Pat Entheogenic therapy Psychedelic medicine |
| Citations | 12 |
| Key finding | Argues that psychedelics may be uniquely suited to reduce chronic shame among sexual and gender minority adults by addressing internalized stigma and minority stress. |
Abstract
Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults.